Active ShortageTier 1: 265.3%PA Req: 397.3%25 Manufacturers40 ANDAs
Albuterol Sulfate HFA is a beta 2 -adrenergic agonist indicated for: Treatment or prevention of bronchospasm in adult and pediatric patients aged 4 years and older with reversible obstructive airwa....
vs. brand Albuterol:Generic saves up to 100% per unit
Active Shortages
2022-10-25Shortage reported, Rising Pharma Holdings, Inc.
2022-10-25Albuterol 0.5% is in stock, though demand remains high; additional supply can be produced as needed., Nephron Pharmaceuticals Corporation
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
RxFinder Drug Intelligence
Ask about drug costs, formulary, 340B
Welcome to RxFinder. I can help with drug acquisition costs, formulary coverage, 340B analysis, and generic competition data. What would you like to know?